Table 4. Annual direct medical cost of COPD and lung cancer attributable to HAP in Morocco in 2019.
| COPD | Lung cancer | ||
|---|---|---|---|
| According to the BOLD I study | According to the modelling analysis | ||
| HAP-related cases (95% CI) |
815 368 (509 160 to 1 163 973) |
661 717 (411 046 to 948 444) |
1356 (775 to 2041) |
| Direct medical cost per person per year (US$) | 791.7 27 |
4455.3 26 |
|
| Annual direct medical cost attributable to HAP (US$) HAP-related cases(95% CI) × direct medical cost per person per year |
645 526 845.6 (403 101 972.0 to 921 517 424.1) |
523 881 348.9 (325 425 118.2 to 750 883 114.8) |
6 041 386.8 (3 452 857.5 to 9 093 267.3) |
| Total annual direct medical cost attributable to HAP ($) HAP attributable cost of COPD (95% CI) + HAP attributable cost of lung cancer (95% CI) |
According to the BOLD I study | 651 568 232.4 (406 554 829.5 to 930 610 691.4) |
|
| According to the modelling analysis | 529 922 735.7 (328 877 975.7 to 759 976 382.1) |
||
BOLD, Burden of Obstructive Lung Disease; COPD, chronic obstructive pulmonary disease; HAP, household air pollution; PAF, population attributable fraction.